Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.

Gut microbiota, probiotics and diabetes

Open access
Gomes, Aline Corado, Bueno, Allain Amador, de Souza, Rávila Graziany Machado, Mota, João Felipe · 2014 · Nutrition Journal

Abstract

Diabetes is a condition of multifactorial origin, involving several molecular mechanisms related to the intestinal microbiota for its development. In type 2 diabetes, receptor activation and recognition by microorganisms from the intestinal lumen may trigger inflammatory responses, inducing the phosphorylation of serine residues in insulin receptor substrate-1, reducing insulin sensitivity. In type 1 diabetes, the lowered expression of adhesion proteins within the intestinal epithelium favours a greater immune response that may result in destruction of pancreatic β cells by CD8+ T-lymphocytes, and increased expression of interleukin-17, related to autoimmunity. Research in animal models and humans has hypothesized whether the administration of probiotics may improve the prognosis of diabetes through modulation of gut microbiota. We have shown in this review that a large body of evidence suggests probiotics reduce the inflammatory response and oxidative stress, as well as increase the expression of adhesion proteins within the intestinal epithelium, reducing intestinal permeability. Such effects increase insulin sensitivity and reduce autoimmune response. However, further investigations are required to clarify whether the administration of probiotics can be efficiently used for the prevention and management of diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2891-13-60

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic representation of probiotic actions in type 1 and type 2 diabetes. Probiotic consumption increases the number of bifidobacteria, and increased expression of adhesion proteins reduces intestinal permeability, impairing the activation of TLR4 by LPS. As result, NFkB activation pathways are blocked. The induction of TH17 cells is also inhibited, preventing pancreatic infiltration of CD8+ T cells.
Figure 1 Schematic representation of probiotic actions in type 1 and type 2 diabetes. Probiotic consumption increases the number of bifidobacteria, and increased expression of adhesion proteins reduces intestinal permeability, impairing the activation of TLR4 by LPS. As result, NFkB activation pathways are blocked. The induction of TH17 cells is also inhibited, preventing pancreatic infiltration of CD8+ T cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 124 references

Research works printed but not linked: 2

  1. WHO - World Health Organization: World Health Statistics WHO/FAO. 2012, Geneva: WHO
  2. WHO - World Health Organization: Joint WHO/FAO Expert Consultation on Geneva. Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001, Cordoba, Argentina: WHO

Cited by

See all 363

Metadata

Authors
Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F.
Affiliations
  • Universidade Federal de Goiás (BR)
  • University of Worcester (GB)
Corresponding author
Mota, João Felipe
Venue
Nutrition Journal
Published
2014-06-17
Volume
13
Issue
1
Pages
60-60
ISSN
1475-2891 (ISSN-L)
OpenAlex
W2125446896
Cited by
363
References
124
Citations by year
2026: 9 · 2025: 21 · 2024: 33 · 2023: 34 · 2022: 44 · 2021: 39 · 2020: 41 · 2019: 35 · 2018: 32 · 2017: 28 · 2016: 26 · 2015: 20 · 2014: 1
FWCI
3.12
Type
journal article
Language
en
Open access
Locations
  • Nutrition Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Americanae (AECID Library) (publishedVersion, other-oa)
  • Worcester Research and Publications (University of Worcester) (acceptedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Funders
  • University of Worcester
  • Fundação de Amparo à Pesquisa do Estado de Goiás
  • Universidade de São Paulo
  • Universidade Estadual Paulista
  • Directorate for Biological Sciences
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
gut microbiota, probiotics, type 2 diabetes, type 1 diabetes, insulin sensitivity, intestinal inflammation, oxidative stress, intestinal permeability, islet autoimmunity, IL-17, IRS-1, diabetes prevention
MeSH terms
Animals, Clinical Trials as Topic, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Inflammation, Insulin Resistance, Probiotics, Gastrointestinal Tract, Toll-Like Receptor 4, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut microbiota, probiotics and diabetes. https://app.cochat.ai/papers/10.1186/1475-2891-13-60
The paper
Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F. (2014). Gut microbiota, probiotics and diabetes. Nutrition Journal. https://doi.org/10.1186/1475-2891-13-60

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.